Jury Renders Defense Verdict in Fosamax Injury Case

NEW YORK - A New York federal jury has found in favor of Merck & Co. in a bellwether Fosamax injury case, determining that the plaintiff does not suffer from osteonecrosis of the jaw as of March 31, 2004. In re Fosamax Products Liability Litigation, No. 06-1789 (S.D. N.Y.).

After deliberating for 30 minutes, the jury rendered the unanimous May 5 verdict. Judge John F. Keenan of the U.S. District Court for the Southern District of New York presided over the trial.

Louise Maley, an Indiana resident, sued Merck, alleging that its osteoporosis drug Fosamax caused her to contract ONJ. …